Ensign Peak Advisors »

Ovid Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7M 988k 2.69

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Applied Materials (AMAT)

View all positions for Ensign Peak Advisors

Top funds holding Ovid Therapeutics

Jupiter Topco
Eventide Asset Management
BlackRock
Henderson Group
RA Capital Management
Affinity Asset Advisors
Vanguard Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Federated Investors
Braidwell
Geode Capital Management
Silverarc Capital Management
Stempoint Capital

View all funds holding Ovid Therapeutics